Pathology of gastrointestinal stromal tumors.

about

Expression of DNMTs and MBD2 in GIST.Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience Cross regulation of signaling pathways in gastrointestinal stromal tumor

P2860

Q38291674-D143EE75-86B0-4B28-A122-CA8C9EDC29FE Q42154228-8308ED9A-9C42-4C54-91AA-D9DB1F48604D Q58572096-1EBB3C9B-EB7E-4C86-9E50-848C50078FCA

P2860

Pathology of gastrointestinal stromal tumors.

Item

http://www.wikidata.org/entity/Q36129663

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pathology of gastrointestinal stromal tumors.

@ast

Pathology of gastrointestinal stromal tumors.

@en

type

Item

label

Pathology of gastrointestinal stromal tumors.

@ast

Pathology of gastrointestinal stromal tumors.

@en

prefLabel

Pathology of gastrointestinal stromal tumors.

@ast

Pathology of gastrointestinal stromal tumors.

@en

P1476

Pathology of gastrointestinal stromal tumors.

@en

P2093

Wai Chin Foo

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.

P304

23-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CPATH.S9689

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bernadette Liegl-Atzwanger

Alexander J. Lazar

P577

2012-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22855636

http://www.w3.org/2001/XMLSchema#string

P932

3408870

http://www.w3.org/2001/XMLSchema#string

Pathology of gastrointestinal stromal tumors.

about

P2860

P2860

Pathology of gastrointestinal stromal tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932